source
- Moderna and Merck report promising results from cancer vaccine amid early skepticismModerna and Merck say their experimental mRNA cancer vaccine has produced encouraging mid‑stage data, shifting the narrative from doubt to optimism. At a March 2023 leadership meeting, executives…
- TwinStrand wins patent lawsuit as GSK’s hepatitis B therapy receives Japanese approvalTwinStrand Biosciences, a DNA sequencing spin‑out from the University of Washington, announced it has prevailed in a patent infringement lawsuit against a California‑based competitor. The court’s…